Apheon Bioscience
Pre-clinicalApheon Bioscience develops targeted protein degradation therapies using molecular glues for oncology and other therapeutic areas.
Founded
2020
Focus
Antibodies
About
Apheon Bioscience develops targeted protein degradation therapies using molecular glues for oncology and other therapeutic areas.
Company Info
TypePrivate
Founded2020
LocationCambridge, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile